THE Food and Drug Administration (FDA) yesterday warned the public against counterfeit medicines against the common cold that are on the market.
Based on Advisory No. 2025-1025, the FDA said the public should be vigilant against fake versions of “Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate + Paracetamol (Decolgen® Forte) 25 mg/ 2 mg/ 500 mg Tablet.”
“All healthcare professionals and the general public are hereby warned as to the availability of this counterfeit drug,” said the FDA.
It noted that the counterfeit version has a lot number that could not be verified with Unilab.
The tablet, knurling, and print appearance, FDA pointed out, also do not resemble the standard features of the registered product.
“Counterfeit drug products in the market pose potential danger or injury to consumers,” stressed the FDA.
The agency warned all establishments and outlets against selling and/or dispensing the said counterfeit product with the above-mentioned features.
“Anyone found selling the said counterfeit drug product will be penalized,” said the FDA.
Similarly, it asked local government units (LGUs) and law enforcement agencies (LEAs) to rid their areas of jurisdiction of such products.
“Please ensure that these products are not sold or made available in your localities or areas of jurisdiction,” said the FDA.
